Correlated Drug Terms (1)

---

	Name (Synonyms)	Correlation
drug2763	blood donation SMS Wiki	0.58

Correlated MeSH Terms (2)

---

	Name (Synonyms)	Correlation
D003863	Depression, NIH	0.15
D018352	Coronavirus Infections NIH	0.04

Correlated HPO Terms (0)

---

	Name (Synonyms)	Correlation

Primary Outcomes

Description: Measure of depressive symptoms. Possible range for the total sum: 0 to 63 (created by summing up the score from each item). Clinical ranges for minimal, mild, moderate and severe major depressive disorder are considered to be 0-13, 13-19, 20-28, and 29-63 points.

Measure: Becks Depression Inventory-II

Time: Change between baseline and end of treatment after seven weeks.

---

Description: Measure of quality of life, total score ranging from 0 to 96 with a higher score indicating a higher quality of life. The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied with the score of an item measuring the perceived importance of the area in question.

Measure: Brunnsviken Brief Quality of Life Scale

Time: Change between baseline and end of treatment after seven weeks.

---

Secondary Outcomes

Description: Measure of depressive symptoms. Possible range for the total sum: 0 to 27 (created by summing up the score from each item). Clinical cut-offs for mild, moderate, moderately severe and severe major depressive disorder are considered to be 5, 10, 15, and 20 points.

Measure: Patient Health Questionnaire

Time: Change between baseline and end of treatment after seven weeks.

---

Description: The Alcohol Use Disorders Identification Test is a 10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems. 10 items and scores ranging from 0-40.

Measure: Alcohol Use Disorder Identification Test

Time: Change between baseline and end of treatment after seven weeks.

---

Description: Measure of insomnia severity and symptoms of disordered sleep. The total score can range between 0 (no sleep problems) to 28 (severe sleep problems and insomnia). Norm score ranges include low likelihood of sleep problems (0 to 7 points), some sleep problems (8 to 14 points), moderate sleep problems (15 to 21 points), severe sleep problems (22 to 28 points).

Measure: Insomnia Severity Index

Time: Change between baseline and end of treatment after seven weeks.

---

Description: Screening for health impact and exposure of the coronavirus pandemic.

Measure: The CoRonavIruS Health Impact Survey

Time: At baseline

---

Description: Assesses subjective distress caused by traumatic events. Items are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). The Impact of Event Scale-Revised yields a total score (ranging from 0 to 88).

Measure: Impact of Event Scale-Revised

Time: Change between baseline and end of treatment after seven weeks.

---

Description: It is a measure of the degree to which situations in one's life are appraised as stressful. It contains 10 items that are scored on a range between 0 (never) to 4 (very often).

Measure: Perceived Stress Scale

Time: Change between baseline and end of treatment after seven weeks.

---

Description: Same as during the treatment phase.

Measure: Becks Depression Inventory-II

Time: Change between posttreatment and 12-month follow-up.

---

Description: Same as during the treatment phase.

Measure: Brunnsviken Brief Quality of Life Scale

Time: Change between posttreatment and 12-month follow-up.

---